Evaluación del Miedo a la Recurrencia del cáncer en españolel Cuestionario de Miedo a la Recurrencia del Cáncer y Escala General del Miedo a la Recurrencia del Cáncer: un estudio piloto

  1. Ibáñez del Prado, Celia
  2. Zontava Aleksandrovna, Volha 1
  3. Cruzado, Juan Antonio 1
  4. Marquina Ospina, Gloria
  5. García Santos, Javier
  6. Rodríguez Nodal, Inés
  7. Bellón del Amo, Mónica
  8. Manzano Fernández, Aránzazu
  9. Casado Herráez, Antonio
  1. 1 Universidad Complutense de Madrid
    info

    Universidad Complutense de Madrid

    Madrid, España

    ROR 02p0gd045

Revista:
Psicooncología: investigación y clínica biopsicosocial en oncología

ISSN: 1696-7240

Año de publicación: 2023

Volumen: 20

Número: 1

Páginas: 155-173

Tipo: Artículo

DOI: 10.5209/PSIC.87576 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Psicooncología: investigación y clínica biopsicosocial en oncología

Objetivos de desarrollo sostenible

Resumen

El objetivo de este estudio es la elaboración de un cuestionario de evaluación del miedo a la recurrencia del cáncer en español. Método: se presenta un estudio piloto de diseño correlacional trasversal elaborado en dos fases: 1) creación del cuestionario del miedo a la recurrencia del cáncer (CMRC) y de la Escala General del Miedo a la Recurrencia del Cáncer (EGMRC); 2) evaluación de sus propiedades psicométricas. Resultados: para la elaboración de los cuestionarios se utilizó el acuerdo entre expertos medido por la V de Aiken. El CMRC queda finalmente configurado con 8 ítems que se responden con una escala tipo Likert de 0-4 y un Alfa de Cronbach de 0,85. La EGMRC de una sola pregunta que se responde con una escala de 0-100 correlaciona hasta un 0,84 con el CMRC. Se utilizó una muestra de 50 mujeres supervivientes de cáncer ginecológico seleccionadas en el Hospital Universitario Clínico San Carlos de Madrid. Ambas escalas correlacionan con el nivel de ansiedad de las pacientes y la función emocional de calidad de vida. No se hallan correlaciones con los niveles de depresión. Conclusiones: El CMRC y la EGMRC son dos instrumentos que pueden ser válidos para la evaluación del miedo a la recurrencia del cáncer en pacientes supervivientes de cáncer ginecológico.

Referencias bibliográficas

  • 1. Estimaciones de la incidencia del cáncer en España, 2023. Red Española de Registros de Cáncer (REDECAN), 2023.
  • 2. Custers JA, Kwakkenbos L, van der Graaf WT, Prins JB, Gielissen MF, Thewes B. Not as stable as we think: a descriptive study of 12 monthly assessments of fear of cancer recurrence among curatively-treated breast cancer survivors 0-5 years after surgery. Front Psychol 2020;11:580979. http://dx.doi.org/10.3389/fpsyg.2020.580979.
  • 3. Fardell JE, Thewes B, Turner J, Gilchrist J, Sharpe L, Smith A’, Girgis A, Butow P. Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation. J Cancer Surviv 2016;10:663-73. http://dx.doi.org/10.1007/s11764-015-0512-5.
  • 4. Galica J, Maheu C, Brennenstuhl S, Townsley C, Metcalfe K. Examining predictors of fear of cancer recurrence using Leventhal’s Commonsense Model: Distinct implications for oncology nurses. Cancer Nurs 2021;44:3-12. http://dx.doi.org/10.1097/ NCC.0000000000000760.
  • 5. Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, Prins J, Dinkel A, Butow P; University of Ottawa Fear of Cancer Recurrence Colloquium attendees. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer 2016;24:3265-8. http://dx.doi.org/10.1007/s00520-016-3272-5.
  • 6. McGinty HL, Small BJ, Laronga C, Jacobsen PB. Predictors and patterns of fear of cancer recurrence in breast cancer survivors. Health Psychol 2016;35:1-9. http://dx.doi. org/10.1037/hea0000238.
  • 7. Xie J, Qi W, Cao L, Tan Y, Huang J, Gu X, et al. Predictors for fear of cancer recurrence in breast cancer patients referred to radiation therapy during the COVID-19 Pandemic: A multi-center cross-section survey. Front Oncol 2021;11:650766. http://dx.doi. org/10.3389/fonc.2021.650766.
  • 8. Otto AK, Soriano EC, Siegel SD, LoSavio ST, Laurenceau JP. Assessing the relationship between fear of cancer recurrence and health care utilization in early-stage breast cancer survivors. J Cancer Surviv 2018;12:775-85. http://dx.doi.org/10.1007/s11764-018-0714-8.
  • 9. Koch L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V. Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship--a multi-regional population-based study. Psychooncology 2014;23:547-54. http://dx.doi.org/10.1002/pon.3452.
  • 10. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, Ozakinci G. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 2013;7:300-22. http://dx.doi.org/10.1007/s11764-013-0272-z.
  • 11. Cappiello M, Cunningham RS, Knobf MT, Erdos D. Breast cancer survivors: information and support after treatment. Clin Nurs Res 2007;16:278-93; discussion 294-301. http:// dx.doi.org/10.1177/1054773807306553.
  • 12. Maheu C, Singh M, Tock WL, Eyrenci A, Galica J, Hébert M, et al. Fear of cancer recurrence, health anxiety, worry, and uncertainty: A scoping review about their conceptualization and measurement within breast cancer survivorship research. Front Psychol 2021;12:644932. http://dx.doi.org/10.3389/fpsyg.2021.644932.
  • 13. Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors--a systematic review of quantitative studies. Psychooncology 2013;22:1-11. https://doi.org/10.1002/pon.3022
  • 14. Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer 2009;17:241-51. http://dx.doi.org/10.1007/s00520-008-0444-y.
  • 15. Vickberg SM. The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med 2003;25:16-24. http://dx.doi.org/10.1207/S15324796ABM2501_03.
  • 16. Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: A systematic literature review of self-report measures. Psychooncology 2012;21:571-87. http://dx.doi.org/10.1002/pon.2070.
  • 17. Mehnert A, Lehmann C, Cao P, Koch U. Die Erfassung psychosozialer Belastungen und Ressourcen in der Onkologie--Ein Literaturüberblick zu Screeningmethoden und Entwicklungstrends [Assessment of psychosocial distress and resources in oncology-a literature review about screening measures and current developments]. Psychother Psychosom Med Psychol 2006;56:462-79. http://dx.doi.org/10.1055/s-2006-951828.
  • 18. Custers JA, van den Berg SW, van Laarhoven HW, Bleiker EM, Gielissen MF, Prins JB. The Cancer Worry Scale: Detecting fear of recurrence in breast cancer survivors. Cancer Nurs 2014;37:e44-50. http://dx.doi.org/10.1097/NCC.0b013e3182813a17.
  • 19. Custers JAE, Kwakkenbos L, van de Wal M, Prins JB, Thewes B. Re-validation and screening capacity of the 6-item version of the Cancer Worry Scale. Psychooncology 2018;27:2609-15. http://dx.doi.org/10.1002/pon.4782.
  • 20. Humphris GM, Watson E, Sharpe M, Ozakinci G. Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7. Health Qual Life Outcomes 2018;16:30. http://dx.doi.org/10.1186/s12955-018-0850-x.
  • 21. Rudy L, Maheu C, Körner A, Lebel S, Gélinas C. The FCR-1: Initial validation of a single-item measure of fear of cancer recurrence. Psychooncology 2020;29:788-95. http://dx.doi.org/10.1002/pon.5350.
  • 22. Aiken, L. Three coeffients for analyzing the reability and validity of ratings. Educ Psychol Meas 1985; 45: 131-43.
  • 23. Penfield RD, Giacobbi PR. Applying a score confidence interval to Aiken’s item contentrelevance index. Meas Phys Educ Exerc Sci 2004; 8:213-25. https://doi.org/10.1207/ s15327841mpee0804_3.
  • 24. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. http://dx.doi.org/10.1111/j.1600-0447.1983.tb09716.x.
  • 25. Caro I e Ibañez E. La Escala Hospitalaria de Ansiedad y Depresión. Boletin de Psicología 1992; 36: 43-69.
  • 26. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69-77. http:// dx.doi.org/10.1016/s0022-3999(01)00296-3
  • 27. Fayers P, Bottomley A; EORTC Quality of Life Group; Quality of Life Unit. Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 2002;38 Suppl 4:S125-33. http://dx.doi. org/10.1016/s0959-8049(01)00448-8.
  • 28. Godoy Fernández MJ, Rojas Tejada AJ, García Puche JL, Cabrera Iboleón J. Fiabilidad y validez de la versión española del EORTC QLQ-C30: Medida de la calidad de vida en pacientes oncológicos avanzados. Rev Psicol Salud 1999; 11: 125-39. https://doi. org/10.21134/pssa.v11i1.796
  • 29. Hernández Blázquez M, Cruzado JA. A longitudinal study on anxiety, depressive and adjustment disorder, suicide ideation and symptoms of emotional distress in patients with cancer undergoing radiotherapy. J Psychosom Res 2016;87:14-21. http://dx.doi. org/10.1016/j.jpsychores.2016.05.010.
  • 30. Mehnert A, Berg P, Henrich G, Herschbach P. Fear of cancer progression and cancerrelated intrusive cognitions in breast cancer survivors. Psychooncology 2009;18:1273- 80. http://dx.doi.org/10.1002/pon.1481.
  • 31. Sharpe L, Thewes B, Butow P. Current directions in research and treatment of fear of cancer recurrence. Curr Opin Support Palliat Care 2017;11:191-6. http://dx.doi. org/10.1097/SPC.0000000000000288.
  • 32. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, Ozakinci G. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 2013;7:300-22. http://dx.doi.org/10.1007/s11764-013-0272-z.
  • 33. Mell CA, Jewett PI, Teoh D, Vogel RI, Everson-Rose SA. Psychosocial predictors of fear of cancer recurrence in a cohort of gynecologic cancer survivors. Psychooncology 2022;31:2141-8. http://dx.doi.org/10.1002/pon.6055.
Fuente de los datos: Dialnet